scispace - formally typeset
Q

Quan Chen

Researcher at Nankai University

Publications -  244
Citations -  20608

Quan Chen is an academic researcher from Nankai University. The author has contributed to research in topics: Medicine & Mitochondrion. The author has an hindex of 52, co-authored 154 publications receiving 16697 citations. Previous affiliations of Quan Chen include Chinese Academy of Fishery Sciences & Chinese Academy of Sciences.

Papers
More filters
Journal ArticleDOI

The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial

TL;DR: In this article , the efficacy and safety of apatinib combined with capecitabine as a second-line therapy or beyond for treating recurrent or metastatic (RM) nasopharyngeal carcinoma (NPC) patients were evaluated.
Journal ArticleDOI

A noncanonical autophagy function of ATG9A for Golgi integrity and dynamics

TL;DR: This recent work reveals a noncanonical function of ATG9A for Golgi dynamics and identifies a pathway for sensing Golgi stress via the MARCHF9-ATG 9A axis.
Journal ArticleDOI

Activation of Na(+) /H (+) exchange on rat preadipocyte plasma membrane and its role in cell proliferation and differentiation.

TL;DR: It is demonstrated that the activation of Na+ /H+ exchange and the resulting pHi increase are the early events related to both proliferation and differentiation of PA.
Journal ArticleDOI

Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020

TL;DR: This cohort study investigates the association of advances in imaging diagnosis, radiotherapy techniques, and treatment methods with survival among pediatric patients with nasopharyngeal carcinoma in China from 1989 to 2020.
Journal ArticleDOI

Prospective study of integrating post-radiotherapy [18F] fluorodeoxyglucose-positron emission tomography/computed tomography scan and plasma Epstein-Barr virus DNA in surveillance of locoregionally advanced nasopharyngeal carcinoma.

TL;DR: In this article , the role of FDG-PET/CT scan at 12-weeks after the end of Radiotherapy (RT) integrated with plasma EBV DNA in surveillance and standardized implementation of locoregionally advanced nasopharyngeal carcinoma (LA-NPC).